Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of MMR Single vs Multidose Presentations in Children
NCT01777529Phase 4Completed
- Sponsor
- Immunobiological Technology Institute
- Start
- Oct 2012
- Primary completion
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of measles, mumps, and rubella vaccine in measles, mumps, rubella, sponsored by Immunobiological Technology Institute. Started Oct 2012; status: completed.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT01777529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777529.